RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.780201
-0.0449 (-5.44%)
Apr 13, 2026, 1:31 PM EDT - Market open

RedHill Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
9.558.046.5361.885.7664.36
Revenue Growth (YoY)
157.62%23.17%-89.43%-27.94%33.25%923.03%
Cost of Revenue
3.43.193.4633.3449.4136.89
Gross Profit
6.164.853.0728.4636.3527.47
Selling, General & Admin
12.4515.5230.9864.0387.9974.66
Research & Development
1.891.593.537.2829.516.49
Other Operating Expenses
--2.3644.06---
Total Operating Expenses
14.3414.7578.5771.31117.4991.15
Operating Income
10.5414.61-12.6342.8481.14-63.68
Interest Income
-2.58-8.4-20.89-13.56-0.05-0.27
Interest Expense
1.352.069.6142.3916.6612.76
Total Non-Operating Income (Expense)
-1.23-6.35-11.2828.8316.6112.49
Pretax Income
9.318.27-23.9271.6797.74-51.2
Net Income
9.318.27-23.9271.6797.74-76.17
Net Income to Common
9.318.27-23.9271.6797.74-76.17
Net Income Growth
-69.14%---26.68%--
Shares Outstanding (Basic)
210000
Shares Outstanding (Diluted)
210000
Shares Change (YoY)
97.35%375.56%320.45%32.46%27.73%22.68%
EPS (Basic)
--100.00-1200.00-2100.002100.00
EPS (Diluted)
--100.00-1200.00-2100.002100.00
EPS Growth
-----50.00%
Shares Outstanding
2.321.291.270.090.050.04
Free Cash Flow
-8.21-9.38-35.83-29.38-65.16-48.99
Free Cash Flow Per Share
-5.31-7.61-138.28-476.76-1400.51-1344.72
Gross Margin
64.45%60.31%47.03%46.06%42.39%42.68%
Operating Margin
110.40%181.69%-193.45%69.33%94.61%-98.95%
Profit Margin
97.52%102.80%-366.25%115.97%113.98%-79.55%
FCF Margin
-85.98%-116.60%-548.71%-47.55%-75.98%-76.11%
EBITDA
10.9115.23-10.645199.28-54.94
EBITDA Margin
114.26%189.38%-162.97%82.52%115.77%-85.36%
EBIT
10.5414.61-12.6342.8481.14-63.68
EBIT Margin
110.40%181.69%-193.45%69.33%94.61%-98.95%
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q